Esophageal disorders

American Journal of Gastroenterology

Volumn 105, Issue 4, 2010, Pages 747-756

  Kahrilas, Peter J ^a   Smout, André J P M ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; CASE REPORT; DYSPHAGIA; ESOPHAGUS ACHALASIA; ESOPHAGUS DISEASE; ESOPHAGUS MANOMETRY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; NUTRITIONAL ASSESSMENT; PHYSICIAN; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SENSATION; SWALLOWING; SYMPTOM; THORAX PAIN;

ADULT; AGED; ALGORITHMS; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL MOTILITY DISORDERS; FEMALE; HUMANS; MALE;

EID: 77950473730     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.65     Document Type: Review

References (42)

1. Vakil N, Zanten van SV, Kahrilas P et al. The Montreal defi nition and classifi cation of gastroesophageal refl ux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-1920
2. Tytgat GN, McColl K, Tack J et al. New algorithm for the treatment of gastro-oesophageal refl ux. Aliment Pharmacol Ther 2008; 27: 249-256
3. Voskuil JH, Cramer MJ, Breumelhof R et al. Prevalence of esophageal disorders in patients with chest pain newly referred to the cardiologist. Chest 1996; 109: 1210-1214
4. Sengupta JN. An overview of esophageal sensory receptors. Am J Med 2000; 108: 87S-9S.
5. Broekaert D, Fischler B, Sifrim D et al. Infl uence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a doubleblind, placebo-controlled study. Aliment Pharmacol Ther 2006; 23: 365-370
6. Rao SS, Mudipalli RS, Remes-Troche JM et al. Theophylline improves esophageal chest pain \a randomized, placebo-controlled study. Am J Gastroenterol 2007; 102: 930-938
7. Chen CL, Orr WC. Comparison of esophageal motility in patients with solid dysphagia and mixed dysphagia. Fall 2005; 20: 261-265
8. Ali KH, Wilson JA. What is the severity of globus sensation in individuals who have never sought health care for it? J Laryngol Otol 2007; 121: 865-868
9. Deary IJ, Wilson JA, Kelly SW. Globus pharyngis, personality, and psychological distress in the general population. Psychosomatics 1995; 36: 570-577
10. Locke GR III, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal refl ux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-1456
11. Howden CW, Chey WD. Gastroesophageal refl ux disease. J Fam Pract 2003; 52: 240-247
12. Gonsalves N, Policarpio-Nicolas M, Zhang Q et al. Histopathologic variability and endoscopic correlates in adults wiTheosinophilic esophagitis. Gastrointest Endosc 2006; 64: 313-319
13. Kapel RC, Miller JK, Torres C et al. Eosinophilic esophagitis: a prevalent disease in the United States that aff ects all age groups. Gastroenterology 2008; 134: 1316-1321
14. Vieth M. Structural abnormalities of endoscopy-negative refl ux disease \real or perceived? Digestion 2008; 78: 24-30.
15. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles Classifi cation. Gut 1999; 45: 172-180
16. Moawad FJ, Veerappan GR, Wong RK. Eosinophilic esophagitis. Dig Dis Sci 2009; 54: 1818-1828
17. Savarino E, Zentilin O, Tutuian R et al. The role of nonacid refl ux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol 2008; 103: 2685-2693
18. Hemmink GJM, Bredenoord AJ, Weusten BLAM et al. Esophageal pHimpedance monitoring in patients with therapy-resistant refl ux symptoms: " on " of " off " proton pump inhibitor? Am J Gastroenterol 2008; 103: 2446-2453
19. Richter JE. Ambulatory esophageal pH monitoring. Am J Med 1997; 103: 130S-4S.
20. Winter JW, Heading RC. The nonerosive refl ux disease\gastroesophageal refl ux disease controversy. Curr Opin Gastroenterol 2008; 24: 509-515
21. Hershcovici T, Zimmerman J. Functional heartburn vs non-erosive refl ux disease: similarities and diff erences. Aliment Pharmacol Ther 2008; 27: 1103-1109
22. Weusten BLAM, Roelofs JMM, Akkermans LMA et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal ph data. Gastroenterology 1994; 107: 1741-1745
23. Wiener GJ, Richter JE, Copper JB et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988; 83: 358-361
24. Pandolfi no JE, Kwiatek MA, Nealis T et al. Achalasia: a new clinically relevant classifi cation by high-resolution manometry. Gastroenterology 2008; 135: 1526-1533
25. Spechler SJ, Castell DO. Classifi cation of oesophageal motility abnormalities. Gut 2001; 49: 145-151
26. Galmiche JP, Clouse RE, Balint A et al. Functional esophageal disorders. Gastroenterology 2006; 130: 1459-1465
27. Fenster PE. Evaluation of chest pain: a cardiology perspective for gastroenterologists. Gastroenterol Clin North Am 2004; 33: 35-40.
28. Wang WH, Huang JQ, Zheng GF et al. Is proton pump inhibitor testing an eff ective approach to diagnose gastroesophageal refl ux disease in patients with noncardiac chest pain? Arch Intern Med 2005; 165: 1222-1228
29. Mudipalli RS, Remes-Troche JM, Andersen L et al. Functional chest pain: esophageal or overlapping functional disorder. J Clin Gastroenterol 2007; 41: 264-269
30. Ott DJ, Kelley TF, Chen MY et al. Evaluation of the esophagus with a marshmallow bolus: clarifying the cause of dysphagia. Gastrointest Radiol 1991; 16: 1-4.
31. Mackenzie SH, Go M, Chadwick B et al. Eosinophilic oesophagitis in patients presenting with dysphagia \a prospective analysis. Aliment Pharmacol Ther 2008; 28: 1140-1146
32. Prasad GA, Talley NJ, Romero Y et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol 2007; 102: 2627-2632
33. M ü ller S, P ü hl S, Vieth M et al. Analysis of symptoms and endoscopic fi ndings in 117 patients with histological diagnoses of eosinophilic esophagitis. Endoscopy 2009; 39: 339-344
34. Kahrilas PJ, Shaheen NJ, Vaezi MF et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal refl ux disease. Gastroenterology 2008; 135: 1383-1391
35. Fox MR, Bredenoord AJ. Oesophageal high-resolution manometry: moving from research into clinical practice. Gut 2008; 57: 405-423
36. Pandolfi no JE, Fox MR, Bredenoord AJ et al. High-resolution manometry in clinical practice: utilizing pressure topography to classify oesophageal motility abnormalities. Neurogastroenterol Motil 2009; 21: 796-806.
37. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngol Head Neck Surg 2003; 11: 485-489
38. Dantas RO, Cook IJ, Dodds WJ et al. Biomechanics of cricopharyngeal bars. Gastroenterology 1990; 99: 1269-1274
39. Harar RP, Kumar S, Saeed MA et al. Management of globus pharyngeus: review of 699 cases. J Laryngol Otol 2004; 118: 522-527
40. Chung JY, Levine MS, Weinstein GS et al. Globus sensation: fi ndings on videofl uoroscopic examinations. Can Assoc Radiol J 2003; 54: 35-40.
41. Takwoingi YM, Kale US, Morgan DW. Rigid endoscopy in globus pharyngeus: how valuable is it? J Laryngol Otol 2006; 120: 42-46
42. Sinn DH, Kim JH, So n HJ et al. Response rate and predictors of response in a short-term empirical trial of high-dose rabeprazole in patients with globus. Aliment Pharmacol Ther 2008; 27: 1275-1281